I mainly look at leukaemias, which are a cancer of the blood. I research how they happen in the first place and what problems with the DNA have to happen to cause a leukaemia. I hope that this will enable me to be able to say which patients are more likely to respond better to chemotherapy drugs, or which could benefit from different drugs.
Comments